In today's healthcare environment, securing regulatory approval is only the beginning. The real challenge lies in ensuring ...

New eTMF module integrates with Enlighten Clinical Solutions’ platform to support inspection-ready clinical trial ...

This article is part of our series on clinical data considerations. Read How to Prepare for Disclosure. For publicly traded biotech companies, disclosing clinical trial data can be an exciting ...

Vizient (R) is proud to announce that the Vizient Clinical Data Base was recognized by Modern Healthcare as one of the Best in Business of 2025. The entire list of winners can be found in the Jan. 12, ...

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or ...

New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...

Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and ...

Physicians, struggling under the pressure of heavy patient loads amidst a national clinical workforce shortage, continue to rank working with EHR systems as the second most challenging part of the job ...

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...

This article is part of our series on clinical data considerations. Read How to Approach Fundraising and Investor Relations. When it comes to disclosing clinical trial data in the biotechnology arena, ...

Patients’ financial resources affect their enrollment in oncology clinical trials to a greater degree than traditional ...